CASC3 and leukemia: Previously, Oerlemans et al. reported that BTZ resistance could be acquired by mutations in the proteasome subunit β5 (PSMB5) in BTZ-adapted leukemia cell lines [6], but we did not find a mutation in the PSMB5 subunit in BTZ-resistant cells (Supplementary Figure S1).